Withholding JAK, IL-17 inhibitors fails to improve COVID-19 vaccine booster response

Retrieved on: 2024-11-17 22:20:29

Tags for this article:

Click the tags to see associated articles and topics

Withholding JAK, IL-17 inhibitors fails to improve COVID-19 vaccine booster response. View article details on hiswai:

Excerpt

WASHINGTON — Withholding Janus kinase or interleukin-17 inhibitors from patients with rheumatoid arthritis or spondyloarthritis does not ...

Article found on: www.healio.com